Wilmington, N.C.-based spine device company TranS1 recently announced a Medicare Administrative Contractor has removed its non-coverage policy for the AxiaLIF procedure effective Jan. 1, 2012, according to a TranS1 news release.
Palmetto GBA has indicated that its medical directors reviewed the AxiaLIF clinical information and recommended coverage for the procedure, which has been supported in the literature as clinically effective. Palmetto provides care to approximately 9 million Medicare beneficiaries in seven states.
With the addition of Palmetto coverage beginning next year, AxiaLIF will be covered for approximately 23 million people nationwide.
Related Articles on Spine Devices:
VertiFlex Completes Superion Interspinous Trial Enrollment
Court Rules Spinal Kinetics Didn't Infringe on Synthes Patent
LDR Moves Headquarters to Bigger Texas Facility
With the addition of Palmetto coverage beginning next year, AxiaLIF will be covered for approximately 23 million people nationwide.
Related Articles on Spine Devices:
VertiFlex Completes Superion Interspinous Trial Enrollment
Court Rules Spinal Kinetics Didn't Infringe on Synthes Patent
LDR Moves Headquarters to Bigger Texas Facility